Sun Pharma in $50 Million deal with Spanish Firm

-

Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 million licensing agreement with Spanish firm Almirall for the development and commercialisation of tildrakizumab for psoriasis in Europe. 

 

In a statement issued late Wednesday night, Sun Pharma said under the terms of the license agreement, Almirall will pay an initial upfront payment of $50 million. 

 

"Phase-3 studies of tildrakizumab have recently been completed. Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales, the terms of which are confidential," the statement said. 

 

Psoriasis is a chronic immune disease that appears on the skin. It affects an estimated 7.5 million people in the US and approximately 125 million people worldwide, the statement said. 

 

For More Information Stock advisory company Indore, Indian Mcx Commodity Tips ,mcx tips ,intraday trading tips, ,stock cash tips, intraday tips, stock future tips ,best stock advisory company in Indore, intraday market tips, nifty future tips, option tips, intraday stock tips, nse bse tips, and you can call us on :- 9827808090

Comments

Post a Comment

Popular posts from this blog

Daily equity Market By Ripplesadvisory Report 16-Aug-2016

-
MARKET WRAP UP The Sensex and Nifty jumped over one per cent on Friday and were headed for their second session of gains, led by energy stocks, including Reliance Industries Ltd, as oil prices extended their rally. Domestic sentiment was also buoyed on continued buying by investors ahead of IIP and inflation data scheduled to be released later in the day. US stocks closed at record highs on Thursday as surging oil prices and strong earnings buoyed investor sentiment, giving a boost to Asian markets. Dealers said widening of positions by participants ahead of key economic data —— industrial production (IIP) for June and consumer price index (CPI) for July —— to be released after market closing today also added to the upbeat investor sentiment. At 3.05 pm, the Sensex was up 315.38 points or 1.13 per cent at 28,174.98 while the NSE Nifty was up 85.7 points or 1.00 per cent at 8,677.85. Sentiment also got a boost as foreign investors continued to buy Indian shares for a...
Read more

Can Doordarshan compete with private news channels?

-
Image
Free Stock Cas Tips- Free Intraday tips and more click here to get your offers >> http://www.ripplesadvisory.com/free-trial.php In all likelihood, starting next year, Doordarshan (DD) will have two separate news channels— one each in Hindi and English. Prasar Bharati, the state-owned broadcaster that runs DD and All India Radio, plans to convert its sociocultural channel DD India into a global English-language news channel on the lines of BBC and Al Jazeera. The move will place DD India in direct competition with private English news channels like Times Now, NDTV 24x7 and Republic TV. Currently, DD India is an international channel with social, cultural and political programming skewed towards Indian audiences living abroad. In a bid to revive DD’s viewership and finances, Prasar Bharati will also convert its current bilingual channel DD News into a full-fledged Hindi news channel that will then have a face-off with private Hindi news channels such as Aaj Tak...
Read more

Oil prices mixed; Brent eases as trade tensions weigh

-
Image
U.S. West Texas Intermediate (WTI) crude futures were up 15 cents, or 0.2 percent, at $68.84 a barrel by 0309 GMT. WTI fell 1.3 percent on Friday. Oil prices were mixed on Monday with U.S. benchmark WTI nudging higher after four weeks of declines, while Brent began the week lower as the fallout from trade tensions weighed on markets. U.S. West Texas Intermediate (WTI) crude futures were up 15 cents, or 0.2 percent, at $68.84 a barrel by 0309 GMT. WTI fell 1.3 percent on Friday. Brent crude futures fell 5 cents to $74.24 a barrel, after notching up a 1.7 percent weekly increase last week, the first gain in four weeks. The U.S. economy grew at its fastest pace in nearly four years in the second quarter, but trade tensions remain high between Washington and Beijing despite an easing between the United States and the EU. "Concerns around the U.S.-China trade wars continue to weigh on prices, while the halt in Saudi shipments through the Red Sea waterway has seemi...
Read more